81 related articles for article (PubMed ID: 33778930)
1. Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort.
Le Van T; Graillon T; Jacob J; Vauleon E; Feuvret L; Boch AL; Boetto J; Boone M; Bronnimann C; Caire F; De Barros A; Delaitre M; Di Stefano AL; Dore M; Ducray F; Dufour C; Engelhardt J; Fontaine D; Froelich S; Helleringer M; Huchet A; Joncour A; Jouanneau E; Mallereau CH; Monfilliette A; Le Fur E; Zemmoura I; Chinot O; Sanson M; Kalamarides M; Loiseau H; Peyre M
J Neurooncol; 2021 May; 153(1):55-64. PubMed ID: 33778930
[TBL] [Abstract][Full Text] [Related]
2. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Kaley T; Barani I; Chamberlain M; McDermott M; Panageas K; Raizer J; Rogers L; Schiff D; Vogelbaum M; Weber D; Wen P
Neuro Oncol; 2014 Jun; 16(6):829-40. PubMed ID: 24500419
[TBL] [Abstract][Full Text] [Related]
3. EANO guideline on the diagnosis and management of meningiomas.
Goldbrunner R; Stavrinou P; Jenkinson MD; Sahm F; Mawrin C; Weber DC; Preusser M; Minniti G; Lund-Johansen M; Lefranc F; Houdart E; Sallabanda K; Le Rhun E; Nieuwenhuizen D; Tabatabai G; Soffietti R; Weller M
Neuro Oncol; 2021 Nov; 23(11):1821-1834. PubMed ID: 34181733
[TBL] [Abstract][Full Text] [Related]
4. Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study.
Graillon T; Ferrer L; Siffre J; Sanson M; Peyre M; Peyrière H; Mougel G; Autran D; Tabouret E; Figarella-Branger D; Barlier A; Kalamarides M; Dufour H; Colin T; Chinot O
Neuro Oncol; 2021 Jul; 23(7):1139-1147. PubMed ID: 33556177
[TBL] [Abstract][Full Text] [Related]
5. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Bush NAO; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR
bioRxiv; 2023 Jul; ():. PubMed ID: 37503127
[TBL] [Abstract][Full Text] [Related]
6. Relative survival after meningioma surgery. A French nationwide population-based cohort study.
Champeaux-Depond C; Constantinou P; Tuppin P; Resche-Rigon M; Weller J
Br J Neurosurg; 2022 Dec; ():1-7. PubMed ID: 36576058
[TBL] [Abstract][Full Text] [Related]
7. Granular clinical history and outcome in 51 patients with primary and secondary malignant meningioma.
Maier AD; Mirian C; Haslund-Vinding J; Bartek J; Guldager R; Møller S; Munch TN; Fugleholm K; Poulsgaard L; Skjøth-Rasmussen J; Ziebell M; Eriksson LE; Scheie D; Poulsen FR; Mathiesen T
J Neurosurg; 2022 Nov; 137(5):1347-1357. PubMed ID: 35276654
[TBL] [Abstract][Full Text] [Related]
8. Perivascular NOTCH3+ stem cells drive meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Oberheim Bush NA; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR
Cancer Discov; 2024 May; ():. PubMed ID: 38742767
[TBL] [Abstract][Full Text] [Related]
9. Will mastering ferroptosis allow treating refractory meningiomas?
Marosi C
Neuro Oncol; 2021 Dec; 23(12):1989-1990. PubMed ID: 34514510
[No Abstract] [Full Text] [Related]
10. The impact of authors' medical specialty on publication patterns and published results of adjuvant radiotherapy for WHO grade 2 meningiomas-a systematic review.
Strand PS; Solheim O
Acta Neurochir (Wien); 2021 Sep; 163(9):2459-2464. PubMed ID: 33779837
[TBL] [Abstract][Full Text] [Related]
11. TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study.
Tabouret E; Fabbro M; Autran D; Hoang-Xuan K; Taillandier L; Ducray F; Barrie M; Sanson M; Kerr C; Cartalat-Carel S; Loundou A; Guillevin R; Mokhtari K; Figarella-Branger D; Delattre JY; Chinot O
Oncologist; 2021 Aug; 26(8):647-e1304. PubMed ID: 33783067
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Methylation Signatures and
Meta R; Boldt HB; Kristensen BW; Sahm F; Sjursen W; Torp SH
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809258
[No Abstract] [Full Text] [Related]
13. MPscore: A Novel Predictive and Prognostic Scoring for Progressive Meningioma.
Liu F; Qian J; Ma C
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33807688
[TBL] [Abstract][Full Text] [Related]
14.
Barone F; Inserra F; Scalia G; Ippolito M; Cosentino S; Crea A; Sabini MG; Valastro L; Patti IV; Mele S; Acquaviva G; Tocco A; Tamburo M; Graziano F; Tomasi OS; Maugeri R; Iacopino G; Cicero S; Strigari L; Umana GE
Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33804251
[No Abstract] [Full Text] [Related]
15. The Stanford stereotactic radiosurgery experience on 7000 patients over 2 decades (1999-2018): looking far beyond the scalpel.
Fatima N; Meola A; Ding VY; Pollom E; Soltys SG; Chuang CF; Shahsavari N; Hancock SL; Gibbs IC; Adler JR; Chang SD
J Neurosurg; 2021 Apr; 135(6):1725-1741. PubMed ID: 33799297
[TBL] [Abstract][Full Text] [Related]
16. Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma.
Patel M; Au K; Davis FG; Easaw JC; Mehta V; Broad R; Chow MMC; Hockley A; Kaderali Z; Magro E; Nataraj A; Scholtes F; Chagnon M; Gevry G; Raymond J; Darsaut TE
Am J Clin Oncol; 2021 Jun; 44(6):258-263. PubMed ID: 33782334
[TBL] [Abstract][Full Text] [Related]
17. PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.
Unterrainer M; Lindner S; Beyer L; Gildehaus FJ; Todica A; Mittlmeier LM; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Tonn JC; Albert NL; Bartenstein P; Ilhan H
Clin Nucl Med; 2021 Aug; 46(8):667-668. PubMed ID: 33782306
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Approaches in the Microsurgical Treatment of 102 Cases of Petroclival Meningioma in a Single Center.
Lin Y; Gao Q; Jin H; Wang N; Xu D; Wang F; Guo AB; Zang W; Li Z; Guo F
Front Neurol; 2021; 12():627736. PubMed ID: 33815255
[No Abstract] [Full Text] [Related]
19. Predictors of Survival in Subtotally Resected WHO Grade I Skull Base Meningiomas.
Da Broi M; Borrelli P; Meling TR
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810089
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
